Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

634
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
634
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

11
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
11
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

310
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
310
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

11
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
11
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

262
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
262
Drug Therapy01:28

Drug Therapy

47
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
47

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxicity of green energy by-products beryllium and tungsten to temperate freshwater species from a Global Biodiversity Hotspot.

Environmental toxicology and chemistry·2026
Same author

Toxicity assessment of green energy by-product, lithium, using a novel suite of eight Australian aquatic-species tests from a Global Biodiversity Hotspot.

Environmental toxicology and chemistry·2026
Same author

Associations of 10-year predicted ASCVD risk by the PREVENT equations with AI-analyzed coronary atherosclerotic plaque characteristics.

American journal of preventive cardiology·2026
Same author

Addressing Unintended Teen Pregnancy Through Reproductive Health Service Delivery by School Nurses and Physicians.

The Journal of school health·2026
Same author

School-Based Health Centers and Use of Effective Contraception among Sexually Active Female Teens in NYC Public High Schools.

Journal of urban health : bulletin of the New York Academy of Medicine·2026
Same author

Sufficient and Efficient Spending on Primary Care Benefits National Health and Health Systems.

The Milbank quarterly·2026

Related Experiment Video

Updated: Jul 11, 2025

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

48.2K

Medication Management of Neuropathic Pain Disorders.

Rebecca Fisher1, Earl Clarkson2

  • 1Department of Oral and Maxillofacial Surgery, Woodhull Medical Center, 760 Broadway, Brooklyn, NY 11206, USA.

Dental Clinics of North America
|November 11, 2023
PubMed
Summary

Oral and Maxillofacial Surgeons must understand neuropathic facial pain disorders, differentiating between episodic and continuous types. Familiarity with conditions like trigeminal neuralgia and effective pharmacologic treatments is crucial for patient care.

Keywords:
Neuropathic pain disordersOrofacial painPostherpetic neuralgiaTrigeminal neuralgia

More Related Videos

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

2.7K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.3K

Related Experiment Videos

Last Updated: Jul 11, 2025

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

48.2K
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

2.7K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.3K

Area of Science:

  • Neurology
  • Oral and Maxillofacial Surgery
  • Pain Management

Background:

  • Neuropathic facial pain presents diagnostic challenges for clinicians.
  • Accurate diagnosis is essential for effective treatment planning.
  • Understanding pain characteristics (episodic vs. continuous) aids in classification.

Purpose of the Study:

  • To review common neuropathic facial pain disorders.
  • To outline appropriate diagnostic considerations.
  • To discuss current pharmacologic management strategies.

Main Methods:

  • Literature review of neuropathic facial pain conditions.
  • Classification of disorders based on pain patterns.
  • Summary of evidence-based treatment options.

Main Results:

  • Episodic neuropathic pain includes trigeminal neuralgia and glossopharyngeal neuralgia.
  • Continuous neuropathic pain encompasses idiopathic trigeminal neuralgia, postherpetic neuralgia, central post-stroke pain, and complex regional pain syndrome.
  • Pharmacologic interventions are available for various neuropathic pain types.

Conclusions:

  • Oral and Maxillofacial Surgeons require comprehensive knowledge of neuropathic facial pain.
  • Distinguishing between episodic and continuous pain is key for diagnosis.
  • Appropriate pharmacologic management is vital for improving patient outcomes.